Tamar Thompson
Insider
First SEC filing: June 5, 2023 · Latest: June 5, 2023
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| July 15, 2026 | CPRX | D | 5,468 | · | · | 0 Direct | -100.00% | Disposed | |
| July 15, 2026 | CPRX | D | 1,894 | · | · | 0 Direct | -100.00% | Disposed | |
| July 15, 2026 | CPRX | D | 1,414 | · | · | 0 Direct | -100.00% | Disposed | |
| July 15, 2026 | CPRX | D | 18,115 | · | · | 0 Direct | -100.00% | Disposed | |
| July 15, 2026 | CPRX | D | 23,248 | · | · | 0 Direct | -100.00% | Disposed | |
| July 15, 2026 | CPRX | D | 29,524 | · | · | 0 Direct | -100.00% | Disposed | |
| July 15, 2026 | CPRX | D | 40,000 | · | · | 0 Direct | -100.00% | Disposed | |
| July 15, 2026 | CPRX | D | 3,773 | $31.50 | $118,850 | 0 Direct | -100.00% | Disposed | |
| Feb. 27, 2026 | RNA | D | 22,000 | · | · | 0 Direct | -100.00% | Disposed | |
| Feb. 27, 2026 | RNA | D | 22,000 | · | · | 0 Direct | -100.00% | Disposed | |
| Feb. 27, 2026 | RNA | D | 13,489 | · | · | 0 Direct | -100.00% | Disposed | |
| Feb. 27, 2026 | RNA | D | 10,034 | · | · | 0 Direct | -100.00% | Disposed | |
| Feb. 27, 2026 | RNA | D | 6,692 | · | · | 0 Direct | -100.00% | Disposed | |
| Dec. 8, 2025 | CPRX | M | 1,413 | · | · | 119,663 Direct | -1.17% | Disposed | |
| Dec. 8, 2025 | CPRX | M | 1,413 | · | · | 3,773 Direct | +59.87% | Acquired | |
| Nov. 21, 2025 | CPRX | M | 947 | · | · | 121,076 Direct | -0.78% | Disposed | |
| Nov. 21, 2025 | CPRX | M | 947 | · | · | 2,360 Direct | +67.02% | Acquired | |
| Nov. 20, 2025 | CPRX | A | 5,468 | · | · | 122,023 Direct | +4.69% | Acquired | |
| Nov. 20, 2025 | CPRX | A | 18,115 | · | · | 116,555 Direct | +18.40% | Acquired | |
| June 10, 2025 | RNA | A | 6,692 | · | · | 6,692 Direct | · | Acquired | |
| June 10, 2025 | RNA | A | 10,034 | · | · | 10,034 Direct | · | Acquired | |
| Dec. 9, 2024 | CPRX | M | 1,413 | · | · | 98,440 Direct | -1.42% | Disposed | |
| Dec. 9, 2024 | CPRX | M | 1,413 | · | · | 1,413 Direct | · | Acquired | |
| Nov. 21, 2024 | CPRX | A | 2,841 | · | · | 99,853 Direct | +2.93% | Acquired | |
| Nov. 21, 2024 | CPRX | A | 23,248 | · | · | 97,012 Direct | +31.52% | Acquired | |
| Oct. 7, 2024 | RNA | M | 30,000 | $27.63 | $828,900 | 30,000 Direct | · | Acquired | |
| Oct. 7, 2024 | RNA | S | 30,000 | $44.98 | $1,349,400 | 0 Direct | -100.00% | Disposed | |
| Oct. 7, 2024 | RNA | M | 30,000 | · | · | 0 Direct | -100.00% | Disposed | |
| June 13, 2024 | RNA | A | 13,489 | · | · | 13,490 Direct | +1348900.00% | Acquired | |
| Dec. 8, 2023 | CPRX | A | 4,240 | · | · | 73,764 Direct | +6.10% | Acquired | |
| Dec. 8, 2023 | CPRX | A | 29,524 | · | · | 69,524 Direct | +73.81% | Acquired | |
| June 15, 2023 | RNA | A | 22,000 | · | · | 22,000 Direct | · | Acquired | |
| June 15, 2022 | RNA | A | 22,000 | · | · | 22,000 Direct | · | Acquired | |
| Jan. 11, 2021 | RNA | A | 30,000 | · | · | 30,000 Direct | · | Acquired |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| July 15, 2026 | CPRX | Restricted Stock Units | Common Stock | · | Nov. 20, 2028 | 5,468 | Disposed |
| July 15, 2026 | CPRX | Restricted Stock Units | Common Stock | · | Nov. 21, 2027 | 1,894 | Disposed |
| July 15, 2026 | CPRX | Restricted Stock Units | Common Stock | · | Dec. 8, 2026 | 1,414 | Disposed |
| July 15, 2026 | CPRX | Options to purchase common stock | Common Stock | $22.77 | Nov. 20, 2032 | 18,115 | Disposed |
| July 15, 2026 | CPRX | Options to purchase common stock | Common Stock | $21.12 | Nov. 21, 2031 | 23,248 | Disposed |
| July 15, 2026 | CPRX | Options to purchase common stock | Common Stock | $14.15 | Dec. 8, 2030 | 29,524 | Disposed |
| July 15, 2026 | CPRX | Options to purchase common stock | Common Stock | $11.60 | May 25, 2030 | 40,000 | Disposed |
| Feb. 27, 2026 | RNA | Stock Option (Right to Buy) | Common Stock | $12.03 | June 14, 2032 | 22,000 | Disposed |
| Feb. 27, 2026 | RNA | Stock Option (Right to Buy) | Common Stock | $12.48 | June 14, 2033 | 22,000 | Disposed |
| Feb. 27, 2026 | RNA | Stock Option (Right to Buy) | Common Stock | $39.96 | June 12, 2034 | 13,489 | Disposed |
| Feb. 27, 2026 | RNA | Stock Option (Right to Buy) | Common Stock | $33.62 | June 9, 2035 | 10,034 | Disposed |
| Dec. 8, 2025 | CPRX | Restricted Stock Units | Common Stock | · | · | 1,413 | Disposed |
| Nov. 21, 2025 | CPRX | Restricted Stock Units | Common Stock | · | · | 947 | Disposed |
| Nov. 20, 2025 | CPRX | Restricted Stock Units | Common Stock | · | · | 5,468 | Acquired |
| Nov. 20, 2025 | CPRX | Options to purchase common stock | Common Stock | $22.77 | Nov. 20, 2032 | 18,115 | Acquired |
| June 10, 2025 | RNA | Stock Option (Right to Buy) | Common Stock | $33.62 | June 9, 2035 | 10,034 | Acquired |
| Dec. 9, 2024 | CPRX | Restricted Stock Units | Common Stock | · | · | 1,413 | Disposed |
| Nov. 21, 2024 | CPRX | Restricted Stock Units | Common Stock | · | · | 2,841 | Acquired |
| Nov. 21, 2024 | CPRX | Options to purchase common stock | Common Stock | $21.12 | Nov. 21, 2031 | 23,248 | Acquired |
| Oct. 7, 2024 | RNA | Stock Option (Right to Buy) | Common Stock | $27.63 | Jan. 10, 2031 | 30,000 | Disposed |
| June 13, 2024 | RNA | Stock Option (Right to Buy) | Common Stock | $39.96 | June 12, 2034 | 13,489 | Acquired |
| Dec. 8, 2023 | CPRX | Restricted Stock Units | Common Stock | · | · | 4,240 | Acquired |
| Dec. 8, 2023 | CPRX | Options to purchase common stock | Common Stock | $14.15 | Dec. 8, 2030 | 29,524 | Acquired |
| June 15, 2023 | RNA | Stock Option (Right to Buy) | Common Stock | $12.48 | June 14, 2033 | 22,000 | Acquired |
| June 15, 2022 | RNA | Stock Option (Right to Buy) | Common Stock | $12.03 | June 14, 2032 | 22,000 | Acquired |
| Jan. 11, 2021 | RNA | Stock Option (Right to Buy) | Common Stock | $27.63 | Jan. 10, 2031 | 30,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| June 5, 2023 | CPRX | Options to purchase Common Stock | 40,000 | Direct |